Search tool

The European market for hashish is currently one of the world’s largest and most profitable. About 647 tonnes of cannabis herb and 641 tonnes of hashish were consumed in the European Union...

The EU Drug Markets Report 2016 is the second comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. Taking an evidence-based approach, the report considers the...

The use of substitution drugs for the treatment of opioid dependence represents a key evidence-based response to heroin problems in Europe. However, the diversion of these medicines from their intended use in...

This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European...

The EU Drug Markets Report 2016 is the second comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis provided in this report spans numerous...

This report includes estimates of the total size of the retail drug market in the European Union (EU) in 2013 for cannabis, heroin, cocaine, amphetamines and ecstasy. October 2018: An error has...

The speed with which the Internet is transforming drug markets poses a major challenge to law enforcement, public health, research and monitoring agencies. This study aims to raise understanding of the current...

Europe has long been one of the world’s largest consumer markets for cannabis, particularly resin imported mainly from Morocco. In this analysis, we report how Europe’s consumer market for cannabis is increasingly...

This study brings together available evidence to provide a comprehensive analysis of cannabis production and markets across the EU. It combines information from EMCDDA routine reporting — data on patterns of prevalence...